May 6, 2025 - 12:21
Bioventus has released its financial results for the first quarter, revealing a revenue of $123.9 million, which marks a decline of 4.3% compared to the same period last year. However, the company saw a positive shift in organic revenue, which advanced by 5.0%. The net loss for the quarter was reported at $0.04 per share, an improvement from a loss of $0.08 per share in the prior-year period.
In terms of non-GAAP earnings, the company reported an increase of 33%, reaching $0.08 per share. This positive trend in non-GAAP earnings reflects the company's efforts to enhance operational efficiencies and drive growth in its core business areas.
Looking ahead, Bioventus has reiterated its guidance for revenue, Adjusted EBITDA, and Non-GAAP EPS for the full year 2025, indicating confidence in its strategic initiatives and market positioning. The company continues to focus on innovations aimed at promoting active healing in its customer base.
